Publications by authors named "Deborah Rustichelli"

Claim this Profile
I
Inter-laboratory method validation of CD34+ flow-cytometry assay: the experience of Turin Metropolitan Transplant Centre.
I F Ivana Ferrero, D R Deborah Rustichelli, S C Sara Castiglia, L G Loretta Gammaitoni, A P Alessandra Polo

EJIFCC· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Xeno-Free Method to Isolate Human Endometrial Mesenchymal Stromal Cells (E-MSCs) in Good Manufacturing Practice (GMP) Conditions.
Stefano Canosa, Katia Mareschi, Elena Marini, Andrea Roberto Carosso, Sara Castiglia, Deborah Rustichelli

Int J Mol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated Platelet Lysate Supports the Proliferation and Immunomodulant Characteristics of Mesenchymal Stromal Cells in GMP Culture Conditions.
Katia Mareschi, Sara Castiglia, Aloe Adamini, Deborah Rustichelli, Elena Marini

Biomedicines· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation.
Katia Mareschi, Aloe Adamini, Sara Castiglia, Deborah Rustichelli, Laura Castello

Pharmaceuticals (Basel)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Mesenchymal Progenitor Cell Expansion is a Predictor of Transplant-related Mortality and acute GvHD III-IV After Bone Marrow Transplantation in Univariate Analysis: A Large Single-Center Experience.
Massimo Berger, Katia Mareschi, Sara Castiglia, Deborah Rustichelli, Alessandra Mandese

J Pediatr Hematol Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity.
Sara Castiglia, Aloe Adamini, Deborah Rustichelli, Laura Castello, Katia Mareschi

J Transl Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity.
Sara Castiglia, Aloe Adamini, Deborah Rustichelli, Laura Castello, Katia Mareschi

J Transl Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoregulatory effects on T lymphocytes by human mesenchymal stromal cells isolated from bone marrow, amniotic fluid, and placenta.
Katia Mareschi, Sara Castiglia, Fiorella Sanavio, Deborah Rustichelli, Michela Muraro

Exp Hematol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions.
Sara Castiglia, Katia Mareschi, Luciana Labanca, Graziella Lucania, Marco Leone, Deborah Rustichelli

Cytotherapy· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of analytical methods in compliance with good manufacturing practice: a practical approach.
Deborah Rustichelli, Sara Castiglia, Monica Gunetti, Katia Mareschi, Elena Signorino

J Transl Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multipotent mesenchymal stromal stem cell expansion by plating whole bone marrow at a low cellular density: a more advantageous method for clinical use.
Katia Mareschi, Deborah Rustichelli, Roberto Calabrese, Monica Gunetti, Fiorella Sanavio

Stem Cells Int· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myogenic potential of whole bone marrow mesenchymal stem cells in vitro and in vivo for usage in urinary incontinence.
Monica Gunetti, Simone Tomasi, Alessandro Giammò, Marina Boido, Deborah Rustichelli

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of In Vitro Exposure of Corticosteroid Drugs, Conventionally Used in AMD Treatment, on Mesenchymal Stem Cells.
Raffaele Nuzzi, Monica Gunetti, Deborah Rustichelli, Barbara Roagna, Francesca Fronticelli Bardelli

Stem Cells Int· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrabone cord blood hematopoietic stem cell transplantation in a subset of very high-risk pediatric patients: a safety and feasibility pilot study.
Francesco Saglio, Massimo Berger, Elena Vassallo, Francesca Nesi, Monica Gunetti, Deborah Rustichelli

J Pediatr Hematol Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of analytical methods in GMP: the disposable Fast Read 102® device, an alternative practical approach for cell counting.
Monica Gunetti, Sara Castiglia, Deborah Rustichelli, Katia Mareschi, Fiorella Sanavio

J Transl Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies.
Monica Gunetti, Alessio Noghero, Fabiola Molla, Lidia Irene Staszewsky, Noeleen de Angelis, Deborah Rustichelli

Cytotherapy· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels.
Katia Mareschi, Deborah Rustichelli, Valentina Comunanza, Roberta De Fazio, Cristina Cravero

Cytotherapy· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients.
Ivana Ferrero, Letizia Mazzini, Deborah Rustichelli, Monica Gunetti, Katia Mareschi

Cell Transplant· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions.
Monica Gunetti, Ivana Ferrero, Deborah Rustichelli, Massimo Berger, Loretta Gammaitoni

Exp Hematol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types.
Katia Mareschi, Monica Novara, Deborah Rustichelli, Ivana Ferrero, Daniela Guido

Exp Hematol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.
Katia Mareschi, Ivana Ferrero, Deborah Rustichelli, Simona Aschero, Loretta Gammaitoni

J Cell Biochem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines.
Alessandra Palmero, Massimo Berger, Claudio Venturi, Ivana Ferrero, Deborah Rustichelli

Oncol Rep· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis